FinTech Growth Fund

FinTech Growth Fund is a London-based investor focused primarily on financial technology, with healthcare exposure concentrated where fintech infrastructure intersects with healthcare payment systems and revenue cycle management. The fund invests in companies building payments rails, billing platforms, claims and remittance technology, and other software where the commercial logic of fintech overlaps with the operational realities of healthcare providers and payers. It is not a healthcare specialist investor, and its participation in the sector is opportunistic rather than thematic. The fund does not market an AI-specific focus, and limited public information is available about its named investment partners working on healthcare-adjacent deals.

The fund concentrates on Series B and Growth-stage rounds, with checks in the $5M to $25M range suitable for companies with substantive revenue and the need to scale enterprise sales, geographic expansion, or regulatory build-out. Geographic focus is the United Kingdom and broader Europe, with selective interest in companies with credible UK customer footprints. The fund typically participates as a syndicate member alongside dedicated healthcare and fintech specialists.

For founders, FinTech Growth Fund is most relevant to those building healthcare software where the core commercial mechanic is payments, billing, or financial workflow rather than clinical care delivery. CEOs should expect diligence focused on financial metrics, regulatory exposure, and platform economics typical of fintech investors. Pure clinical or therapeutics founders, or early-stage health tech companies, are unlikely fits. For payments-and-billing-oriented health tech operators in the UK, however, the fund offers domain-aligned growth capital from investors who understand both sides of the stack.